secwatch.observer — SEC 8-K summary
======================================

Issuer:     Phreesia, Inc. (PHR)
CIK:        0001412408
Form:       8-K
Filed at:   2022-09-07T23:59:59+00:00
Accession:  0001412408-22-000049
Event type: earnings
Sentiment:  neutral
Materiality: 0.65
Item codes: 2.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Phreesia Q2 FY2023 revenue $67.9M (+33% YoY); raises FY revenue and EBITDA guidance
--------------------------------------------------------------------------------

- Revenue $67.9M, up 33% YoY; average healthcare clients 2,776 (+40% YoY).
- Adjusted EBITDA loss widened to $26.0M from $11.0M in prior year.
- FY2023 revenue guidance raised to $273M-$275M; Adj. EBITDA guidance improved to negative $106M-$109M.
- Cash $240.7M, down $73.1M from Jan; expects $165M-$170M by Jan 31, 2023.
- Average revenue per healthcare client $18,248, down 7% YoY as client growth outpaced payment volume.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1412408/000141240822000049/0001412408-22-000049-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1412408/000141240822000049/phr-20220907.htm
  HTML page:      https://secwatch.observer/filing/0001412408-22-000049

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer